Commitment to Action

Partners for Cancer Diagnosis and Treatment in Africa

Commitment by

American Society for Clinical Pathology

In 2015, the American Society for Clinical Pathology (ASCP) and a coalition of partners committed to provide patients in underserved areas of Sub-Saharan Africa and Haiti access to rapid cancer diagnostics and appropriate care and treatment. The ASCP-led coalition will develop an economical, scalable, secure, and reliable telemedicine solution, that will evolve into a cloud-based system, to register specimens, record findings, and disseminate diagnostic results to local clinicians and build capacity to provide care and treatment options for patients. Leveraging this technology will allow local clinicians to upload biopsies and receive diagnostic results from pathologists in the United States within 24-72 hours. This commitment will enable a level of diagnostic care currently scarce or unavailable in Sub-Saharan Africa, while building the capacity of local medical doctors and laboratory professionals.

Share

Tabs

Overview
Summary

Commitment

Partners for Cancer Diagnosis and Treatment in Africa

Launched

2015

Est. Duration

3 years

Estimated Total Value

$43,356,000

Region

Africa, Latin America & Caribbean

Countries

BOTSWANA, HAITI, LESOTHO, LIBERIA, RWANDA, SWAZILAND

Commitment by

American Society for Clinical Pathology

Partner(s) of the Commitment Maker(s)

Union for International Cancer Control, National Institutes of Health, IBM, The Institute for Health Metrics and Evaluation, Pfizer Inc, Technossus, Roche Diagnostics Corporation, Sakura Finitek, Partners In Health, Omnyx LLC